Legal Opinion
Al Haj v. Pfizer Inc.
District Court, E.D. Illinois
Decided August 3, 2018No. 17 C 6730PublishedCited by 18 opinions
1Opinion of the Court
Gary Feinerman, United States District Judge *818On behalf of himself and a putative nationwide class, Karmel Al Haj alleges in this diversity suit that Pfizer Inc. deceives consumers by charging more for "Maximum Strength" Robitussincough syrup than for "Regular Strength" Robitussin even though the former has a lower concentration of active ingredients than the latter. Doc. 1. Applying Bristol-Myers Squibb Co. v. Superior Court of California , --- U.S. ----, 137 S.Ct. 1773, 198 L.Ed.2d 395 (2017), the court granted Pfizer's motion under Civil Rule 12(b)(2) to dismiss the claims of Al Haj's…
2Cases cited20 opinions
- Hanson v. DencklaSupreme Court of the United States · 1958
- Ruhrgas Ag v. Marathon Oil Co.Supreme Court of the United States · 1999
- Insurance Corp. of Ireland v. Compagnie Des Bauxites De GuineeSupreme Court of the United States · 1982
- Bristol-Myers Squibb Co. v. Superior Court of Cal., San Francisco Cty.Supreme Court of the United States · 2017
- American Pipe & Construction Co. v. UtahSupreme Court of the United States · 1974
15 more not listed; retrieve them via the Exa API.
3Cited by18 opinions
- Florence Mussat v. IQVIA, Inc.Court of Appeals for the Seventh Circuit · 2020
- Michael Molock v. Whole Foods Market, Inc.Court of Appeals for the D.C. Circuit · 2020
- Knotts v. Nissan N. Am., Inc.District Court, D. Maine · 2018
- Al Haj v. Pfizer IncDistrict Court, N.D. Illinois · 2020
- Al Haj v. Pfizer IncDistrict Court, N.D. Illinois · 2019
13 more not listed; retrieve them via the Exa API.